MERCK Kommanditgesellschaft auf Aktien
MER
Rank in Stocks
#323
Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the... Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the healthcare, life science, and electronics sectors. The company is actively involved in the research, development, production, and commercialization of both pharmaceutical and biological prescription medications. These treatments target a range of medical conditions, including those in neurology, immunology, oncology, fertility, and cardiometabolic and endocrine disorders. Furthermore, its life science division furnishes essential products, instruments, and services to support research facilities, pharmaceutical and biotechnology manufacturing, and industrial as well as analytical testing laboratories. Within its electronics segment, MERCK supplies crucial materials for integrated circuits, liquid crystals, organic light-emitting diodes (OLEDs), photoresists, smart antenna systems, and liquid crystal glazing solutions. It also produces specialized effect pigments extensively utilized in applications such as automotive coatings, cosmetics, and various industrial and plastics manufacturing. MERCK maintains strategic partnerships with Pfizer Inc., has an agreement with Novartis AG, and holds license arrangements with Debiopharm International SA and MoonLake Immunotherapeutics AG. Established in 1668, the firm's headquarters are located in Darmstadt, Germany, and it operates as a subsidiary of E. Merck Kommanditgesellschaft.
Share Price
$171.67
Last synced: 2026-07-13
Market Cap
$74.64B
Change (1 day)
0.00%
Change (1 year)
-
Country
DE
Trade MERCK Kommanditgesellschaft auf Aktien (MER)
Category
Healthcare
Number of shares outstanding for MERCK Kommanditgesellschaft auf Aktien (MER)
Number of shares outstanding as of October 2026: 0
According to MERCK Kommanditgesellschaft auf Aktien latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of October 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for MERCK Kommanditgesellschaft auf Aktien (MER) from 2002 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2025 | 434.78M | 0.00% |
| 2022 | 434.78M | 0.00% |
| 2021 | 434.78M | 0.00% |
| 2020 | 434.78M | 0.00% |
| 2019 | 434.78M | 0.00% |
| 2018 | 434.78M | 0.00% |
| 2017 | 434.78M | 0.00% |
| 2016 | 434.78M | 0.00% |
| 2015 | 434.78M | 0.00% |
| 2014 | 434.78M | 0.00% |
| 2013 | 434.78M | 0.00% |
| 2012 | 434.78M | -0.01% |
| 2011 | 434.80M | 0.00% |
| 2010 | 434.80M | 0.00% |
| 2009 | 434.80M | 0.00% |
| 2008 | 434.80M | 0.69% |
| 2007 | 431.80M | 9.58% |
| 2006 | 394.05M | 1.68% |
| 2005 | 387.55M | 0.63% |
| 2004 | 385.12M | 0.21% |
| 2003 | 384.30M | 10.00% |
| 2002 | 349.37M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
|
| - | - |
CN
|
